Table 3 Analysis of neutropenia across all treatments (classification National Cancer Institute Common Toxicity Criteria for Adverse Events (NCI CTCAE) grade ≥1 vs. grade 0)
Toxicity | n (univariable analysis) | n (multivariable analysis) | BCSS | RFS | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Unadjusted | Adjusted | Unadjusted | Adjusted | |||||||
HR (95Â % CI) | P value | HR (95Â % CI) | P value | HR (95Â % CI) | P value | HR (95Â % CI) | P value | |||
Neutropenia | 5,886 | 5,211 | 0.86 (0.77–0.96) | 0.009 | 0.87 (0.77–0.99) | 0.03 | 0.91 (0.83–0.99) | 0.04 | 0.91 (0.82–1.01) | 0.07 |